⚠ COVID-19 INFORMATION: Vaccine Information, Other Resources 

A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old

Official Title: A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old

The primary objectives of this study are to describe the single-dose pharmacokinetics (PK) of intravenous (IV) tedizolid phosphate or an oral suspension of tedizolid phosphate, when administered to pediatric participants, full-term neonates, and preterm neonates.

NCT03217565
Muller, William J., MD, PhD
Interventional
Yes

Contact Information:

Laura Fearn

Research Nurse

312.227.6285